Cardiovascular Systems shareholders have an opportunity to recover their investment losses. Click "Join this Class Action" above.
Cardiovascular Systems Inc.
Rosen Law Firm announces that it has filed a class action lawsuit on behalf of purchasers of Cardiovascular Systems Inc. securities (NASDAQ: CSII) from September 12, 2011 through January 21, 2016, all dates inclusive (the “Class Period”) resulting from allegations that Cardiovascular Systems may have issued materially misleading business information to the investing public.
If you purchased Cardiovascular Systems stock from September 12, 2011 through January 21, 2016 and would like to join the action, please click "Join This Class Action" above.
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Cardiovascular Systems Inc. - CSII
New York, N.Y., February 12, 2016. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Cardiovascular Systems Inc. securities (NASDAQ: CSII) from September 12, 2011 through January 21, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Cardiovascular Systems investors under the federal securities laws.
To join the Cardiovascular Systems class action, go to the firm’s website at http://rosenlegal.com/cases-738.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE
According to the lawsuit, throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Cardiovascular Systems distributed illegal kickbacks to health care providers; (2) Cardiovascular Systems engaged in the off-label promotion of its medical devices; and (3) Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices. As a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 12, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-738.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827